LMR Partners’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
LMR Partners's IONS Position: Q3 2026 in Review
LMR Partners increased its Ionis Pharmaceuticals (IONS) stake by 644% in Q3 2026, buying an estimated $11.3M and bringing the position to 229,249 shares worth $10.2M. The position accounts for 0.03% of the portfolio, ranked #455.
LMR Partners first reported a position in IONS in Q3 2016 and has held it in 9 quarters since. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- LMR Partners held 229,249 shares of Ionis Pharmaceuticals worth $10.2M as of Q3 2026.
- LMR Partners bought 198,449 Ionis Pharmaceuticals shares in Q3 2026, an estimated $11.3M.
- Ionis Pharmaceuticals made up 0.03% of LMR Partners's portfolio in Q3 2026, its #455 holding.
- LMR Partners first reported a position in Ionis Pharmaceuticals in Q3 2016 and has held it in 9 quarters since.
- 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.